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Abstract 
Hepatic solute transport is a complex process whose disruption is associated with liver disease and 
drug-induced liver injury.  Intravital multiphoton fluorescence excitation microscopy provides the spatial and 
temporal resolution necessary to characterize hepatic transport at the level of individual hepatocytes in vivo 
and thus to identify the mechanisms and cellular consequences of cholestasis.  Here we present an overview 
of the use of fluorescence microscopy for studies of hepatic transport in living animals, and describe how we 
have combined methods of intravital microscopy and digital image analysis to dissect the effects of drugs and 
pathological conditions on the function of hepatic transporters in vivo.  
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1. Introduction 
 A primary function of the liver is to regulate the constitution of the blood, mediating the metabolism and 
excretion of endogenous and exogenous compounds.  The critical role of these processes is demonstrated by 
the serious pathologies associated with mutations in the proteins that mediate hepatic metabolism and 
transport.  Hepatic transport is of particular interest in pharmaceutical development.  In addition to mediating 
the metabolism and clearance of drugs, the liver is frequently the victim of off-target drug effects.  In particular, 
drug-induced liver injury, one of the most expensive and vexing problems in drug development, is associated 
with drugs that inhibit hepatocyte secretory function [1-3].  
The transport of drugs and metabolites is accomplished by proteins that mediate transport from the 
sinusoid capillaries into the hepatocyte cytosol, from the hepatocyte cytosol to the bile canaculi or from the 
hepatocyte cytosol back into the sinusoids.  The major uptake transporters include proteins of the Solute 
Carrier family, e.g. OATP (SLC01A2, SLC21A6 SLC21A8, SLC21A9), OCT (SLC22A1) and NTCP (SLC10A1).  
Major secretory transporters include proteins of the ATP-binding Cassette transporter family, such as MRP2 
(ABCC2), MDR3 (ABCB4)  and BSEP (ABCB11), which mediate canalicular secretion) and MRP3 (ABCC3) 
and MRP4 (ABCC4), which mediate sinusoidal reflux back into the blood).  Drugs may impact one or more of 
these transporters in such a way as to increase or decrease the metabolism and clearance of drugs and 
metabolites.   Furthermore, depending upon the balance of effects on uptake and secretory transporters, a 
cholestatic drug may induce the accumulation of a drug or toxic metabolite in the hepatocyte cytosol, inducing 
liver injury.  It is thus critical to not only determine that a drug disrupts normal liver transport, but also to 
determine the site(s) of transport disruption.   
While the effects of drugs on the function of specific transporters can be sensitively measured in 
studies of isolated membrane vesicles, the additional complexity of the in vivo situation makes it difficult to 
extrapolate these measurements to predictions of in vivo effects, particularly since local in vivo drug 
concentrations are typically unknown.  Transport can also be evaluated in studies of cultured cells.  While 
hepatocytes grown in vitro recapitulate many in vivo functions, particularly when grown in sandwich culture, 
results obtained from these systems can also be difficult to extrapolate to the in vivo condition.  First, 
depending upon culture conditions, transporter expression levels change to varying degrees after isolation.  
Second, cultured cells lack the structure of the lobule, a transport unit in itself that is organized such that 
substrates are sequentially transported and metabolized by hepatocytes with different and independently-
regulated populations of transporters [4-8].  Third, these simple systems lack the systemic inputs that 
dynamically regulate the abundance and distribution of hepatic transporters in vivo [9-13], making them 
incapable of reproducing the complex circumstances of pathological conditions, such as infection. 
Conversely, the standard imaging and biochemical approaches used in animal studies can detect 
cholestasis, but provide only indirect evidence as to underlying mechanisms.  The ideal system for dissecting 
hepatic transport would provide the spatial and temporal resolution necessary to distinguish the individual 
steps of transport, but in the relevant physiological context, consisting of differentiated hepatocytes in the multi-
cellular environment of the intact liver lobule, with intact vascular, immune and endocrine inputs.  In addition to 
  
supporting dissection of drug effects under physiological conditions, such a system would support studies of 
the effects of pathology on liver transport and studies of the effects of drugs in the context of pathology. 
Studies of isolated and cultured hepatocytes have demonstrated that fluorescence microscopy provides 
the spatial and temporal resolution necessary to characterize transport of fluorescent probes [14-17].  The 
same general approach can be applied to studies of hepatic transport in vivo using intravital microscopy of the 
liver of laboratory animals.  As early as 1945, a crude fluorescence microscope system was used to study the 
effects of various insults on transport of fluorescein in the rat liver [18].  Approximately 40 years later, digital 
epifluorescence microscopy was used to characterize transport of fluorescein and fluorescein-glycocholate in 
the livers of rats and hamsters [19, 20].  In the past twenty years, investigators have capitalized on the 
increased reach and resolution of multiphoton fluorescence excitation microscopy to evaluate transport of 
fluorescein and other fluorescent probes in rats [21-26] and mice [27, 28].  Figure 1 shows an example of a 
multiphoton fluorescence excitation image collected from the liver of a rat 20 minutes after intravenous 
injection of rhodamine dextran (retained in the vasculature) and sodium fluorescein (transported into 
hepatocytes and bile canaliculi).  The inset demonstrates that the resolution provided by multiphoton 
microscopy is sufficient to clearly resolve sinusoids, hepatocytes and bile canaliculi.  Here we describe how we 
have combined methods of intravital microscopy and image analysis to quantify the effects of drugs and 
disease on l transport in vivo. 
 
2.  Approach 
2.1  Overview  -  The intravital microscopy transport assays described here are based upon quantitative 
analysis of images collected in time series from the liver of a living rodent following intravenous injection of 
fluorescent transport substrates, largely following previously described approaches [22, 23].  Images collected 
in this way demonstrate that fluorescein uptake and secretion proceed very rapidly.  Figure 2 shows that within 
a minute of perfusion, detectible levels of fluorescein are present not only in the hepatocyte cytosol, but also in 
bile canaliculi.  Within 6 minutes of perfusion, a substantial amount of fluorescein has already been transported 
into canaliculi.  Panel F shows that fluorescein secretion into canaliculi is essentially blocked in rats treated 
with the cholestatic agent taurolithocholate (TLC).  The 10 minute time course of fluorescein transport in the 
presence or absence of TLC is shown in Video 1.    
 
2.2  Surgical preparation and presentation of the rat liver on the microscope stage - All studies described 
here were approved and conducted according to the Institutional Animal Care and Use Committee guidelines 
of Indiana University, and adhere to the guide for the care and use of animals [29] 
Experimental animals are typically acclimatized for a period of at least 4 days and, depending upon the 
study, fasted for 16 hrs prior to studies.  Adult Sprague Dawley (or Wistar) rats, weighing between 180 and 400 
grams, are sedated with 5% Isoflurane, weighed and 130mg/kg Inactin is administered intraperitoneally for 
anesthesia.  Anesthesia is monitored by evaluation of responses to gentle pinching of ears and feet.  The rat is 
placed on a heating pad to maintain body temperature.  Body temperature is monitored using a rectal 
thermometer, and heart rate and respiratory rate are monitored visually. 
  
Once anesthetized, a 3 x 1.5 cm, L-shaped incision is made 1 cm to the right of the ventral midline in 
the neck.  A jugular cannula is then placed using PE 50 tubing filled with sterile 0.9% saline and attached to a 
Luer stub adapter and 1 mL syringe.  The neck is sutured with 3-0 black silk sterile suture.  At this time, a bolus 
of Hoechst 33342 (Invitrogen, 2 mg/kg) diluted in 0.9% sterile saline to a total volume of 0.4 mL is injected into 
the jugular line to label cell nuclei [30].   
The liver is exposed for imaging by making a 4 cm incision across the torso 1 to 2 cm below the middle 
of the rib cage. A wet (0.9% saline) 2x2 gauze sponge is gently placed below the left lateral liver lobe.  In order 
to minimize tissue motion for microscopy, the liver is tethered to the bottom of a 50 mm Willco coverslip-
bottomed dish (GWST-5040, Warner Instruments, Hamden, Ct).  Tape is placed on the periphery of the glass 
window of the dish, and cyanoacrylate glue is applied to the tape.  The glass window is pressed to the liver and 
the gauze on either side of the liver is gently pressed and glued to the tape using cotton-tipped applicators. 
Alternatively, the liver itself may be glued directly to the coverglass along the periphery of the window.  Sterile 
0.9% saline is then placed in the coverslip-bottomed dish to keep liver moist throughout the imaging session.  
A small dose (0.2mg/kg) of sodium fluorescein (Fluka Analytical) is administered IV in order to generate dim 
labeling of bile canaliculi that can be used to facilitate positioning of the liver at the beginning of the study.   
 
2.3  Multiphoton microscopy - The studies described here were conducted using two Olympus Fluoview 
1000 microscope systems.  Images shown in Figures  1, 2, 4, 7  and 8 were collected using an Olympus 
Fluoview 1000 MPE laser scanning confocal/multiphoton microscope system mounted to an IX81 inverted 
microscope stand, equipped with a Spectraphysics MaiTai DeepSee titanium sapphire laser (Spectraphysics, 
Santa Clara, CA).  Fluorescence emissions were collected in three non-descanned photomultiplier detectors, 
with bandpass filters for blue (420-460 nm), green (495-540 nm) and red (570-630 nm) fluorescence 
emissions.  The image shown in Figure 5 was collected using an Olympus Fluoview 1000 laser scanning 
confocal microscope system modified for multiphoton fluorescence excitation imaging.  This system is mounted 
to an IX81 inverted microscope stand and is fitted with a Spectraphysics MaiTai titanium sapphire laser 
(Spectraphysics, Santa Clara, CA), a Pockels cell electro-optical attenuator (Conoptics Inc., Danbury, CT), and 
a Keplerian collimator/beam expander.  Images are collected via a custom designed 3 channel external 
detector system equipped with gallium arsenide phosphide detectors (Hamamatsu, Hamamatsu City, Japan) 
with bandpass filters for blue (380-480 nm), green (500-550 nm) and red (560-650 nm) fluorescence 
emissions.  Images were collected using IR-optimized water immersion objectives: either an Olympus 20X, NA 
0.95 objective or an Olympus 25X, NA 1.05, objective.  
Fluorescence excitation is accomplished using illumination wavelengths from 800-830 nm. Images are 
generally collected at a rate of approximately 1 frame per second at a frame size of 512 by 512 pixels.  Zoom 
and focal plane spacing are typically set for a voxel size of 0.7 by 0.7 by 1 micron.  Photomultiplier voltages are 
adjusted such that minimal laser power yields images with detectible fluorescence in the hepatocyte cytosol 
before addition of probe.  A guiding principle in intravital microscopy is to limit the level of illumination in order 
to avoid photo-toxicity and photobleaching of fluorescent probes.  For our studies, we typically evaluate the 
effect of imaging by comparing images of the field used to characterize kinetics with images of nearby fields for 
  
evidence of damage (reduced microvascular flow, microvascular leakage, disrupted cell integrity) or 
photobleaching. 
In order to ensure that measurements are comparable between different animals, replicate studies are 
conducted using the same objective lens and identical laser power and detector settings.  Reproducible 
measurements of multiphoton-excited fluorescence additionally depend upon use of the same excitation 
wavelength and pulse duration.  Insofar as signal levels in intravital microscopy also depend upon the depth at 
which images are collected in the tissue, all images are collected from the same depth in the tissue (typically 
10-20 microns in our studies). 
 Quantitative measurements depend upon signal linearity.  Detector offset should be adjusted to ensure 
collection of weak signals, and accurate estimation of background fluorescence.  Illumination and detector gain 
must be adjusted such that the strongest signals are detected without saturating the detector.  In practice, the 
dynamic range of laser scanning confocal/multiphoton microscope systems is such that it can be exceeded 
due to the enormous range of fluorescence intensities in different compartments over the course of a time-
series.  Nonetheless, accurate measurements of transport kinetics can typically be obtained as long as signal 
saturation is avoided during the initial intervals of hepatocyte uptake and secretion. 
 
2.4  Fluorescent probes for intravital microscopy analyses of hepatic transport 
 
2.4.1 - Fluorescent probes for analysis of organic anion transport - Fluorescein and its derivatives are the most 
commonly used fluorescent transport probes [31].  Fluorescein exhibits minimal toxicity (LD50 of 1 g/kg in rats) 
and fluorescein-based probes have been used in hepatic transport studies for more than 70 years [18-25, 27, 
28].  Fluorescein is an organic anion substrate of the human and rat organic anion (OAT/Oat and OATP/Oatp) 
transporters [32] Human MRP2 [33, 34] that is rapidly glucuronidated in hepatocytes [35-37], making it an 
appropriate probe for MRP2- and MRP3-mediated anion glucuronate secretion. 
Modified forms of fluorescein have also been widely used to study hepatic transport.  Dichloro-
fluorescein is also a substrate for rat Oatp, Mrp2 and Mrp3 [38], but we find that its utility in vivo is 
compromised by significant quenching of its fluorescence by constituents of the serum. 
6-carboxyfluorescein diacetate (6-CFDA) is another fluorescent probe that has been widely used to 
evaluate transport in vitro, [39] and in vivo [27, 28].  As shown in Figure 3A, intravenous injection of 6-CFDA 
results in the rapid transport of the fluorescent probe into bile canaliculi within minutes of administration.  6-
CFDA differs from fluorescein in that it is membrane permeant, but upon exposure to esterases becomes 
highly charged, so that while its uptake is passive, its secretion depends upon active transport, which is 
mediated by Mrp2 and Mrp3 in rat hepatocytes [38].   
In studies of the in vivo effects of rifampin on hepatic transport, we attempted to exploit the membrane 
permeability of 6-CFDA to evaluate effects on the secretory pathway [22].  We had found that rifampin 
essentially blocked hepatic uptake of fluorescein confounding our ability to assess the effect of rifampin on 
hepatocyte secretory function.  We anticipated that passive uptake would yield sufficient cytosolic delivery of 6-
CFDA to support analysis of the effects of rifampin on secretion. However, we found that, like fluorescein, the 
  
uptake of 6-CFDA was inhibited by rifampin.  In retrospect, it is likely that this result reflects hydrolysis of the 
intravenously-delivered 6-CFDA in the blood to its membrane impermeant form.  Previous studies 
demonstrated that esterases present in the blood rapidly hydrolyze Carboxy-Dichlorofluorescein Diacetate 
(CDFDA) [38] and various fluorescent probes containing acetoxy-methyl esters [40], eliminating their capacity 
for passive cell permeability in vivo.  Thus, although 6-CFDA can be used to evaluate hepatic transport in vivo, 
it should be used with the understanding that hepatic uptake is likely to be at least partially mediated by active 
transport processes. 
 
2.4.2 - Fluorescent probes for analysis of bile acid transport – Cholyl-lysl-fluorescein (CLF) is a fluorescein-
labeled bile acid that has been previously used to evaluate hepatic transport in vitro [16, 41] and in vivo  [42]. 
Figure 3B shows an image of the liver of a living rat 10 minutes after intravenous injection of CLF.  Studies of 
Mrp2-deficient TR- rats suggest that hepatic secretion of CLF is independent of Mrp2 and is mediated by Bsep 
in rats [43, 44].  In contrast, studies of transfected cells suggest that CLF secretion is mediated by MRP2 rather 
than BSEP in humans [45].   
Cholyl-glycyl-amido-fluorescein (CGamF), is a fluorescent bile acid whose transport, in a comparison 
with a variety of other fluorescent bile acids was found to most closely resemble native bile acids [46].  Hepatic 
uptake of CGamF is mediated by Ntcp/NTCP, but primarily by Oatps/OATP [47-50], while CGamF secretion is 
mediated by BSEP/Bsep [47, 51].  Figure 3C shows an example of an image that demonstrates the uptake 
and canalicular secretion of CGamF by hepatocytes in the liver of a living rat following intravenous injection. 
 
2.4.3 - Additional fluorescent probes for in vivo studies of hepatic transport – Although the preponderance of 
intravital microscopy studies of hepatic transport utilize fluorescein or a derivative, the reader is also referred to 
additional probes have been used for in vivo studies, including the long wavelength dyes DY635 and 
indocyanine green [26, 52], NBD-conjugates of bile acids [46, 53] and rhodamine-123 [54].   
Most epifluorescence systems (wide-field, confocal or two-photon excitation) are designed to collect 
multiple colors of fluorescence, supporting simultaneous characterizations of multiple properties.  So, for 
example, fluorescent dextrans can be used alongside fluorescent transport substrate to characterize 
microvascular function [27, 28, 55].  Throughout this review we show how Hoechst 33342 can be used to label 
nuclei, providing spatial cues for identifying and distinguishing cells.  In previous studies, we have shown that 
Hoechst can also be used to identify apoptotic cells, which are apparent on the basis of their 
condensed/fragmented nuclei [30, 56].  Figure 3D shows an how propidium iodide, a membrane-impermeant, 
DNA-binding probe can be used to identify necrotic hepatocytes in a field of the liver collected from a rat 3 hrs 
after treatment with acetaminophen.  The close proximity of the patch of necrotic cells alongside fields of 
healthy hepatocytes actively transporting fluorescein highlights the focal nature of acetaminophen-induced liver 
injury. 
 
2.5  Intravital microscopy imaging procedures - The microscope stage is warmed with heating pads, and 
the objective lens is heated with an objective heater.   The rat is placed ventral side down on the stage of an 
  
inverted microscope and the attached coverslip-bottom dish is inserted into the 50 mm stage aperture and 
taped in place.  A second heating pad is then placed over the rat.  The hind legs of the rat are then taped 
securely to prevent movement.  A schematic diagram of the arrangement of the rat on the microscope stage is 
shown in Figure 4.  The depth of anesthesia is monitored by visual inspection of respiration and core 
temperature is monitored via rectal thermometer.  Blood pressure can be monitored via a transducer attached 
to a femoral artery catheter. 
 Using wide-field epifluorescence viewed through the microscope eyepiece, an appropriate field, 
focused to a depth of the first layer of hepatocytes is identified using the dim fluorescence of the fluorescein-
labeled canaliculi.  Microvascular flow is also apparent in epifluorescence, and is used to ensure that the blood 
flow to the liver has been maintained during preparation for imaging.  The field is then scanned using laser 
scanning multiphoton excitation to identify the top and bottom of a 6 micron deep volume that incorporates an 
extensive network of sinusoids and canaliculi (such as that shown in Figure 2).  Using these settings, a series 
of 3D image volumes (6 focal planes, spaced 1 micron apart) are then collected continuously just before and 
for ten minutes following injection of a fluorescent probe.  Unrestricted blood flow, apparent in the rapid 
movement of the shadows of blood cells through the sinusoids is monitored throughout the interval.  In order to 
minimally increase blood volume, probes are introduced in minimal volumes, typically to a total of 0.4 ml.   
  
2.6  Digital image analysis - Quantitative data are derived from the time-series images using methods of 
digital image analysis.  The methods described below were developed using Metamorph image processing 
software (Molecular Devices, Downington, PA), but are based upon simple tools available in other image 
processing packages.   
 
2.6.1 -  Production of extended depth images - projection of image volumes – The kinetics of probe transport 
are captured as a time-series of 3D volumes, rather than a series of images of single planes.  This approach is 
taken to minimize the effects of motion on quantitative analyses.  The quantitative assays described below 
depend upon measuring changes in fluorescence occurring in subcellular compartments that are separated by 
fractions of a micron.  In order to make measurements of each of these compartments over time, the field must 
thus be immobilized to subcellular precision.  While sample stability is easily accomplished in studies of 
cultured cells, it is more challenging in studies of cells in living animals, particularly for the liver, since it is 
located immediately below the diaphragm. 
 Much of the respiration-induced motion is eliminated by tethering the liver to the coverslip-bottomed 
dish (as described above).  The elimination of horizontal motion is demonstrated in Figure 5, which shows the 
results of a study in which 139 sequential images of nuclei were collected from a single image plane in the liver 
of a living rat. The absence of horizontal motion is apparent in the sharp appearance of the nuclei in the 
maximum projection of the entire series of images shown in Panel A, but is especially obvious in Panel B, 
which shows an XT projection of the region indicated in the red box.  This image demonstrates that the sample 
has been immobilized to essentially single pixel lateral stability (0.7 microns). 
  
 However, examination of the XT projection shows that there are gaps where nuclei disappear from the 
time series.  These gaps reflect vertical motion of the tissue sufficient to move the nuclei beyond the focal 
plane. In order to accommodate this residual vertical motion, we effectively capture a larger focal volume by 
collecting each time point as a 3D volume.  Each of these 3D volumes is then converted into a single, 
extended-focus image by maximum-projection.  We find that this approach ensures that the structure of the 
canaliculi and sinusoids are more consistently captured, regardless of small vertical translations in the tissue.  
The effectiveness of this approach for quantitative studies is demonstrated in Figure 6, which shows that the 
wild variability obtained from an analysis of a time series of single images (Panel C) is substantially reduced in 
measurements obtained from time series of the projected image volumes (Panel D).   
This approach also has the effect of capturing more of the canalicular network in the field; whereas the 
canaliculi are fragmented in the image of a single focal plane (Panel A), the canalicular network is much more 
complete in the maximum projection of 6 focal planes.  The effectiveness of this approach for maintaining the 
canalicular network in the field of view throughout the time series is also demonstrated in Video 2. 
 
2.6.2 - Quantitative analysis of transport via measurements of regions-of-interest drawn in individual cells – As 
mentioned above, we quantify hepatocyte transport in vivo by quantifying changes in the fluorescence of the 
cytosol and bile canaliculi in image volume projections collected from the liver over time after intravenous 
injection of a fluorescent transport substrate. 
One approach is to measure changes in mean fluorescence in regions of interest that are manually 
drawn over the cytosol and bile canaliculi of individual cells [22, 23].  The mean fluorescence in each region is 
then automatically measured for each image in the time series, producing a series of values reflecting the 
kinetics of probe fluorescence changes in the compartment.  Using this approach, the rate of hepatocyte 
uptake is measured as the initial linear rate of increase in fluorescence in regions of interest measured in the 
cytosol of 20-50 hepatocytes (typically during the first 30 seconds after perfusion).  The rate of canalicular 
secretion is measured in regions of interest located over the canaliculi of the same hepatocytes (typically 
during the period from 30 seconds to 2 minutes after perfusion).  Signal linearity is established by (1) verifying 
that intensity measurements do not exceed detector saturation and (2) subtracting the mean fluorescence 
measurements obtained prior to perfusion from all measurements.  
Quantitative analyses of the image series shown in Video 1 are shown in Figure 7.  Rate calculations 
demonstrate that treatment with the cholestatic agent taurolithocholate reduces the rate of fluorescein uptake 
by nearly 60% and the rate of fluorescein secretion by more than 50%.  These results suggest that TLC inhibits 
both uptake and secretion, however the effect on secretion is less obvious when one considers the lower 
amount of fluorescein in the cytosol of hepatocytes of the TLC-treated rat.  Insofar as the rate at which 
fluorescein appears in the canaliculi depends upon the concentration of fluorescein in the cytosol, we may 
want to measure secretion in terms of “specific secretion”, in which the raw rate of secretion is divided by the 
mean cytosolic fluorescence.  Measured in this way, the effect of TLC is much less obvious, reducing the rate 
of specific secretion by only ~10%. 
  
Insofar as kinetics are measured in terms of changes in detected fluorescence, reproducibility between 
measurements made in different animals depends upon fastidious maintenance of imaging conditions.  All 
imaging must be conducted with identical plasma concentrations of fluorescein, at the same depth into the liver 
at identical levels of illumination, and with identical photomultiplier settings.  Despite unavoidable variability in 
each of these parameters, reproducibility in these transport assays is high.  We previously found that a sample 
size of 5 rats was sufficient to detect a 20% decrease in the rate of hepatic uptake of fluorescein in an 
experimental model of chronic kidney disease [23]. 
 
2.6.3 - Quantitative analysis of field-wise transport via automatically-generated regions of interest – The 
method described above is based upon characterizing a sample of cells that are deemed representative of the 
field, if not the liver.  In this regard, this approach is effective for evaluating the effects of experimental 
manipulations that have a relatively consistent effect on all of the hepatocytes in a field.  To the degree that 
responses vary between cells, the validity of this method is susceptible to sampling error.  An example of a 
heterogeneous response is shown in Video 3, which shows that canalicular transport is blocked in most, but 
not all of the hepatocytes in a field collected from a rat 2 hrs after IV injection of 4 mg/kg endotoxin.  While a 
cell-by-cell analysis might yield interesting insights as to focal effects of endotoxin, for example as a function of 
position in a lobule, it would be difficult to design a cell sampling approach that would support estimation of the 
overall effect on the entire field.  To facilitate simple, bias-free measurements of the response of an entire field, 
we developed techniques for measuring hepatocyte uptake and secretion using automatically identified 
regions-of-interest for the cytosol and canaliculi. 
Field-wise canalicular transport is quantified as the change in the integrated fluorescence of the green 
channel in automatically-generated masked regions generated using a high-pass spatial filter.  The approach is 
predicated on the fact that canaliculi appear as narrow structures that are detectibly brighter than the 
surrounding cytosol. Since Hoechst fluorescence bleeds into the green channel on our systems, each of the 
projected images of the green channel is first crosstalk-corrected by subtraction of the corresponding image of 
the blue channel.  A high-pass filtered image is then obtained by subtraction of a large-neighborhood median-
filtered image [57].  The final canalicular mask is obtained by elimination of single pixels from the high-pass-
filtered image.  The effectiveness of this approach for automatically delineating the region of bile canaliculi is 
demonstrated in Figure 8 and Video 4.   
A time series of masks is generated and canalicular fluorescence for each time point is quantified as 
the integrated signal of the green channel occurring within the masked region.  Measurements are corrected 
for background by subtracting the mean signal measured prior to introduction of the fluorescent probe.  As 
described above, canalicular secretion rate is quantified as the linear slope during initial interval of canalicular 
accumulation (typically 1 minute after infusion, ~2 minutes after injection).  
 Field-wise cytosolic transport is quantified as the change in mean green-channel fluorescence in a set 
of automatically generated regions-of-interest in the cytosol of hepatocytes, defined as 2 pixel wide regions 6 
pixels away from the boundary of the nuclei. Masks of the nuclei in each projected image are first created by 
thresholding images of the blue channel, which contains images of Hoechst-labeled nuclei.  Cytosolic regions-
  
of-interest are generated by dilating the objects in the binarized image of the nuclei 8 times and then 
subtracting the resulting mask from a binary mask of the image created by dilating 6 times (in each case, using 
a neighborhood of 3).  Overlap of canaliculi with the cytosolic regions-of-interest is eliminated by subtracting 
the corresponding canalicular mask from each.  Examples of representative cytosolic regions-of-interest are 
shown in Figure 8.  Cytosolic fluorescence for each time point is quantified as the mean green channel signal 
occurring in the cytosolic regions-of-interest, after subtraction of the mean integrated signal measured prior to 
introduction of the fluorescent probe.  Cytosolic uptake rate is quantified as the linear slope during initial 
interval of cytosolic uptake accumulation (starting immediately upon infusion, typically 1 minute after injection). 
This automated approach for identifying the canalicular and cytosolic regions offers several advantages 
over the single-cell analysis procedure.  First, the automated approach provides measures of field-wise 
responses that are less susceptible to bias, since it does not depend upon operator identifying cells and 
regions for quantification.  Second, the automated procedure requires significantly less time and effort than the 
single cell approach, which requires manually drawing regions of interest.  Finally, it is less sensitive to motion 
artifacts.  Insofar as the manual technique utilizes a single mask of the regions-of-interest, accurate 
measurements depend upon the continuous alignment of the images with the single region mask throughout 
the time series.  In contrast, the automated approach generates regions-of-interest from each image in the time 
series, and so is insensitive to lateral motion in the field. 
An example of a field-wise analysis of hepatic transport is shown in Figure 9, which summarizes the 
effects of endotoxin on fluorescein transport in rats.  Figure 9A shows a projected image of a field collected 
from the liver of a rat 1 hour after intraperitoneal injection of 4 mg/kg bacterial endotoxin.  When compared with 
the comparable image collected from a control animal (Figure 1), this image clearly demonstrates how 
endotoxin treatment induces an accumulation of fluorescein in the cytosol of hepatocytes.  The overall effects 
of endotoxin are also dramatically demonstrated in Video 3, which shows a comparison of fluorescein transport 
by a control rat and a rat 2 hours after endotoxin treatment.   
The quantitative analysis of field-wise canalicular fluorescence shown in Figure 9B demonstrates that 
fluorescein secretion is completely blocked 1 hour after treatment with endotoxin, and is only beginning to 
recover by 2 hours.  This result is consistent with in vivo studies of rats and ex vivo studies of human liver 
slices demonstrating that endotoxins induce a rapid internalization of three major canalicular transporters 
Mrp2, Bsep and aquaporin8, resulting in decreased bile secretion [58-63]. 
The analysis of cytosolic fluorescence shown in Figure 9C demonstrates that the rate of fluorescein 
uptake is essentially unaffected by endotoxin so that, in the absence of canalicular secretion, fluorescein 
accumulates to cytosolic concentrations increase 2-3 fold over those in the control rat.  
Figure 10 shows the results of a similar analysis of the effects of TLC on hepatic transport of the 
fluorescent bile acid CGamF.  Quantitative analysis of field-wise measurements demonstrate that TLC reduces 
the rate of CGamF secretion by 8 fold (Figure 10A), while having no effect on the rate of uptake (Figure 10B).  
As found in rats treated with endotoxin, unabated uptake in the absence of secretion leads to a protracted 
accumulation of CGamF in the hepatocyte cytosols of TLC treated rats. 
 
  
3.  Conclusions 
These studies demonstrate that the speed and resolution of quantitative intravital microscopy can be 
used to provide unique insights into the mechanism and consequences of cholestasis in vivo.  The complexity 
of hepatic transport, which for any given substrate involves multiple transporters, each of which is 
physiologically regulated, makes it difficult to predict in vivo effects from results obtained from in vitro studies.  
Extrapolating the in vivo effects of a drug from in vitro data is further complicated by the complexity of factors 
determining local in vivo drug exposures.  Quantitative intravital microscopy provides a direct window into the 
realized, in vivo effects of a drug, integrated across all of these variables.   
In addition to identifying net effects, intravital microscopy is also uniquely capable of distinguishing 
acute effects on uptake and secretion, and determining whether transport is disrupted in such a way as to 
increase the cytosolic concentration of transport substrates.  The ability to detect acute effects on the cytosolic 
load of transport substrates may be particularly useful in that the cytosolic accumulation of drugs and/or toxic 
metabolites is believed to mediate the hepatotoxicity of many drugs associated with drug-induced liver injury 
[1-3].  The relationship between cytosolic substrate accumulation and cytotoxicity is complicated by the fact 
that the adaptive changes in transporter expression made by hepatocytes during cholestasis are also believed 
to be mediated by the cytosolic accumulation of bile acids [12, 64-66]. 
 
4.  Challenges and outlook 
4.1 -  Microscopy provides a small window – can observations be extrapolated to the entire organ? - 
Intravital microscopy provides a high-resolution window into hepatic transport, but the window is small; our 
studies of transport kinetics are conducted using 20-25X objectives, providing a field of view less than 400 
microns across.  To some degree, one can validate observations made in a small field by collecting data from 
multiple fields, but the kinetics of probe clearance are such that it is difficult to collect kinetic data for more than 
2-3 fields from a single animal.  One can also build a larger-scale mosaic from images collected from 
contiguous regions (i.e. Figure 1).  However, these mosaics take tens-of-minutes to collect and so, while they 
can be useful for characterizing spatial heterogeneity in probe transport, they cannot provide kinetic data at the 
timescale of hepatic transport. 
 The obvious solution would be to image at lower magnification; a 2.5X objective could be used to image 
an area 100x larger than a 25X objective.  The problem is that, for conventional objective lenses, low power 
objectives necessarily also have low numerical apertures, compromising resolution and light collection 
efficiency.   Alternative light-collection schemes have been developed to increase the efficiency of light 
collection in multiphoton microscopy [67, 68], however these do not improve the problem of resolution.  A 2.5X 
objective with numerical aperture of .07 will provide lateral resolution around 4-fold too low to resolve bile 
canaliculi.  New scanner and lens designs have recently been developed that provide sub-micron resolution 
over 5-6 mm fields [69, 70] but, at the time of writing, these systems are not commercially available. 
 The window into the liver is also very shallow; our studies are typically conducted at depths of only 10-
20 microns into the liver.  Insofar as the reach of light microscopy is limited by scattering and refractive index 
  
discontinuities, it may be increased by using longer wavelengths of light [71] and/or using beam shaping 
approaches such as adaptive optics [72], respectively.   
However, these improvements need to be put in perspective – at best they may increase our field of 
view from the scale of microns to the scale of millimeters, still laughably small relative to the total volume of a 
single lobe, much less the entire liver.  In the end, intravital microscopy studies should be complemented with 
conventional approaches.  While conventional analyses of blood and bile samples cannot reproduce, much 
less validate measures of subcellular kinetics, they can provide complementary evidence that they are 
representative [24] 
 
4.2 -  Effects of intravital microscopy on liver function – have we perturbed the system we’re 
evaluating? - The rationale for intravital microscopy is that it provides access to the behaviors of cells in the 
complete, relevant context of the intact living animal.  However, the procedures involved in intravital 
microscopy are, to varying degrees, invasive and thus can perturb normal function.  As described here and in 
other articles in this volume, investigators make every effort to ensure the physiological condition of animals on 
the microscope stage.   
One concession that most investigators make is to use general anesthetics, which themselves can 
affect hepatic transport [73, 74] and potentially introduce drug-drug interactions that complicate studies.  
Anesthesia is necessary for imaging animals using conventional microscope systems, but miniaturized 
microscopes have been developed that can be mounted on the skull or back, to support imaging of physiology 
in non-anesthetized “awake” animals [75, 76].  While “miniaturized”, current systems remain too bulky for 
imaging visceral organs in freely-moving animals. 
Our studies utilize animals whose livers are imaged within minutes of surgical exposure.  In order to 
avoid collecting data immediately following the trauma of surgery, imaging can be delayed through the use of a 
window chamber that can be implanted the day before [28].   Similar windows have been refined to the point 
that they can be used to repeatedly image tissues over periods of weeks, supporting powerful longitudinal 
studies [77].  Windows of this kind are described in detail in another article in this issue. 
 
4.3 - Building quantitative models from data obtained from intravital microscopy studies - The utility of 
quantitative fluorescence microscopy for studies of hepatic transport is based upon a few critical assumptions.  
First, it depends upon the validity of using fluorescent probes as proxies for molecules of interest (drugs, bile 
acids).  As described in section 2.4, there are multiple fluorescent probes that have been validated as 
substrates for the transporters involved in hepatic transport.   
 Second, fluorescence microscopy assays of transport kinetics depend upon the assumption that 
measurements reflect probe concentrations.  In fact, measured fluorescence is a function not only of 
concentration, but also of the efficiency with which fluorescence is stimulated and collected, and the linearity 
with which collected fluorescence is converted into a digital signal.  These issues can be addressed through a 
thoughtful and consistent approach to imaging, as described in Section 2.3.  However, the relationship 
between fluorescence and concentration is complicated by the fact that probe fluorescence is reduced by 
  
binding to proteins and, in the case of fluorescein, from enzymatic modification to fluorescein glucuronide, 
which profoundly reduces fluorescence [35, 46].  Thus, even if one were to calibrate fluorescence 
measurements to account for differences in the illumination and fluorescence detection, it is not possible to 
assign a concentration to a fluorescence measurement without a complete understanding of the degree to 
which fluorescein’s fluorescence is quenched in different compartments at different times.   
A promising approach to measuring fluorescence quenching in vivo is to complement measures of 
fluorescence intensity with measures of fluorescence lifetime, which decreases proportionally with quenching.  
The Roberts lab has pioneered the use of intravital fluorescence lifetime microscopy of the liver [21, 24, 25, 
78].  Recently-developed systems supporting rapid measurement of fluorescence lifetime may make it possible 
to sensitively measure the kinetics of fluorescence intensity and fluorescence lifetimes in the blood, hepatocyte 
cytosol and canaliculi in vivo.  To the degree that fluorescence lifetimes can be used to estimate quenching, 
this approach could be used to translate measures of intensity into measures of probe concentration in each 
compartment over time and thus to estimate transport parameters based upon Michaelis-Menten kinetics.  
These kinetic parameters could be compared directly with results obtained from in vitro studies, for example to 
estimate local in vivo drug concentrations.  These parameters could also be used to populate models of in vivo 
transport that could identify effects on transport pathways that cannot be directly evaluated, for example, 
transport from hepatocytes back into the sinusoids. 
 
4.4 -  Clinical application of intravital microscopy for studies of hepatic function - Generally an invasive 
procedure, high-resolution intravital microscopy is almost exclusively conducted in studies of animal models.  
However, the approaches described here are remarkably compatible with clinical application.  First, both 
fluorescein and indocyanine green are approved for use in human studies.  Second, the surface of the liver can 
be accessed via laparoscopy, a procedure in which imaging is conducted using a narrow probe inserted 
through a minor incision in the abdomen.   
 The feasibility of fluorescence laparoscopy as an approach for evaluating hepatic function was 
demonstrated nearly 30 years ago in studies in which a wide-field epifluorescence probe was used to image 
fluorescein in the liver of humans and rats [79].  The approach has since been refined with the development of 
a confocal endo-microscope that provides resolution sufficient to distinguish sinusoids, hepatocytes and 
canaliculi in humans following intravenous injection of fluorescein [80].  Using systems of this kind, assays of 
liver function, developed in intravital microscopy studies of animal models, may find clinical application as a 
means to understand cholestasis and perhaps predict cholestatic liver injury.  
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Table 1 – Commercially available probes used for intravital studies of hepatic transport 
Transport assay Probe Dose Vendor Reference 
Organic anion 
uptake and 
secretion 
Sodium fluorescein 2 mg/kg Sigma Aldrich (St. Louis, MO, USA) [18-25, 27] 
Indocyanine green 10 µg/kg Pulsion Medical Systems SE 
(Feldkirchen, Germany) 
[26, 52] 
Rhodamine-123 2 mg/kg Sigma Aldrich (St. Louis, MO, USA) [54] 
DY635 10 µg/kg Dyomics GmBH (Jena, Germany) [26, 52] 
Organic anion 
secretion 
6-Carboxyfluorescein 
diacetate 
0.2 mg/kg Sigma Aldrich (St. Louis, MO, USA) [22, 27, 28] 
Bile acid uptake 
and secretion 
Cholyl-lysl-
fluorescein 
0.5 mg/kg Syncon 
(Groningen, Netherlands) 
[42-44] 
Cholyl-glycyl-amido-
fluorescein 
0.4 mg/kg WuXi AppTec 
(Tianjin, China) 
This chapter 
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Figure captions 
 
Figure 1 – Intravital multiphoton microscopy of the liver of a living rat - Montage of nine image volumes 
collected from the liver of a living rat 20 minutes after injection of 6 mg/kg 2 M MW rhodamine dextran (red), 
and 2 mg/kg sodium fluorescein (green).  Each of the nine panels of this mosaic is a maximum projection of 15 
images collected over a depth of 15 microns. Scale bar depicts 100 micron length.  Inset shows a 3X 
magnification of a maximum projection of a 6 micron thick volume, showing the clear resolution of the 
sinusoids (red, labeled with rhodamine dextran), the hepatocyte cytosol (dim fluorescein fluorescence) and bile 
canaliculi (bright fluorescein fluorescence).  Inset image also shows nuclei, labeled with 2 mg/kg Hoechst 
33342 (blue).  Figure adapted from cover figure published in Intravital, 2013, Volume 5, number 3.  Used with 
permission. 
 
Figure 2 – Fluorescein transport in the liver of a living rat - Sequence of multiphoton excitation 
fluorescence images collected from the liver of a living rat before (A), and at various times after IV injection of 2 
mg/kg sodium fluorescein (green) (B - E).  Nuclei were labeled by intravenous injection of 2 mg/kg Hoechst 
33342 (Blue) 30 minute prior to fluorescein injection.  F – Similar study conducted in a rat treated with 15 
mg/kg taurolithocholate (TLC), showing impaired fluorescein transport.  Each image is a maximum projection 
of 6 images collected through a 6 micron volume.  Scale bar depicts 100 micron length.  Contrast in the green 
channel of all panels was enhanced nonlinearly by adjusting gamma to 0.8. 
 
Figure 3 – Additional probes suitable for labeling the liver following intravenous injection – Maximum 
projections of image volumes collected from the livers of living rats following intravenous injection of 2 mg/kg 
Hoechst (Invitrogen, Carlsbad, CA, blue) and A - 0.2 mg/kg 6-CFDA (Sigma-Aldrich, St. Louis, MO, 0.2 mg/kg, 
green), B - 0.5 mg/kg CLF (Syncom, Groningen, Netherlands, green), C – 0.4 mg/kg CGamF (WuXi AppTec, 
Tianjin, China, green), D – 2 mg/kg sodium fluorescein (Sigma-Aldrich, St. Louis, MO, green) and 4mg/kg 
propidium iodide (Invitrogen, Carlsbad, CA).  Image shown in panel D was collected from the liver of a rat 3 
hours after intraperitoneal injection with 1 g/kg acetaminophen. Necrotic cells are apparent from the purple-
  
white labeling of nuclei resulting from the combination of Hoechst (blue) and propidium iodide (yellow to red).  
Scale bar depicts 100 micron length. 
 
Figure 4 – Schematic diagram of the arrangement of a rat for intravital microscopy using an inverted 
microscope - Following surgery, the liver is exteriorized and attached to a coverslip-bottomed dish, which is 
inserted into the stage insert on the stage of inverted microscope.  Imaging is conducted from below using a 
water immersion objective.  Body temperature is maintained using warming pads placed under and over the 
animal, and by an objective heater wrapped around the microscope objective.  Figure adapted from figure 
previously published in Intravital (Babbey et al., 2012).  Used with permission. 
 
Figure 5 – Stabilization of the rat liver for high-resolution intravital microscopy – A – Maximum 
projection of 139 sequential images of Hoechst-labeled nuclei collected over a period of approximately 2.5 
minutes from the liver of a living rat.  B -  “XT” maximum projection of the region enclosed in the red box in 
panel A, in which the horizontal dimension shows the distribution of projected fluorescence across the region 
and the vertical dimension shows the distribution over time.  Scale bar depicts 100 micron length.  Contrast in 
both panels was enhanced non-linearly by adjustment of gamma to 0.87. 
 
Figure 6 – The effects of vertical motion can be mitigated by maximum projection of image volumes – A 
– Single image collected from the liver of a living rat following IV injection of 2 mg/kg sodium fluorescein.  B – 
Maximum projection of the 6 plane, 6 micron thick volume collected from the same field.  C – Quantifications of 
integrated fluorescence in 4 regions-of-interest placed over segments of bile canaliculi, obtained from a series 
of individual images.  D – Quantifications of integrated fluorescence in 4 regions-of-interest placed over 
segments of bile canaliculi, obtained from a series of projected image volumes. Scale bar depicts 50 micron 
length.  The time series of individual images and projected volumes is shown in Video 2.  Figure previously 
published in Intravital (Babbey et al., 2012).  Used with permission. 
 
Figure 7 – Measurements of fluorescein transport in individual hepatocytes in vivo – The mean 
fluorescence was measured over time in regions of interest in the cytosol (crosses), bile canaliculi (open 
  
circles) and adjacent sinusoids (closed circles) for hepatocytes in a control rat (A) or in a rat 30 min after 
intravenous injection of 15 mg/kg TLC (B).  Values are presented as means ± SEM.  Data were obtained from 
the images shown in Video 1.  Note that the plateau in canaliculi measurements obtained from the control 
animal result from detector saturation.  Figure modified from version previously published in American Journal 
of Physiology (Regulatory, Integrative and Comparative Physiology) (Ryan et al., 2014).  Used with permission. 
 
Figure 8 – Automated generation of regions-of-interest for quantitative analyses of hepatic transport - 
Automated methods of digital image analysis were applied to original projected image volumes (panel A, 
CGamF displayed in green, Hoechst-labeled nuclei displayed in blue) to automatically segment regions of 
canaliculi (panel B) or hepatocyte cytosols (panel C) for automated quantification of the kinetics of secretion 
and uptake, respectively.  Panel D shows canalicular regions of interest (red) and cytosolic regions of interest 
(white) overlaid over the original image.  The nearly-complete overlap between the green canalicular 
fluorescence of the original image with the red signal of the segmented image (appearing as yellow) 
demonstrates the effective segmentation of the canalicular regions.  The entire sequence of automatically-
generated canalicular regions, alongside the original projected images is shown in Video 4.   Scale bar is 50 
microns in length. Visibility of nuclei in panel A was enhanced by non-linear adjustment of the intensity in the 
blue channel, using a gamma of 1.2. 
 
Figure 9  - Quantitative analysis of the effect of endotoxin (LPS) on hepatic transport of fluorescein in rats -  A 
– Maximum projection of an image volume collected from the liver of a living rat injected with rhodamine 
dextran (red) and fluorescein (green) 1 hour after intraperitoneal injection of 4 mg/kg endotoxin.  Scale bar 
depicts 100 micron length.  B – Quantifications of field-wise total canalicular fluorescence as a function of time 
after intravenous injection of sodium fluorescein for control rats (solid black symbols), rats 1 hour after 
endotoxin injection (solid red symbols) and rats 2 hours after endotoxin injection (open red symbols).  C – 
Quantitative analysis of mean cytosolic fluorescence (± SEM) as a function of time after intravenous injection 
of sodium fluorescein for control rats (solid black symbols), rats 1 hour after endotoxin injection (solid red 
symbols) and rats 2 hours after endotoxin injection (open red symbols). 
 
  
Figure 10  - Quantitative analysis of the effect of TLC on hepatic transport of CGamF in rats -  A –
Quantifications of field-wise total canalicular fluorescence as a function of time after intravenous injection of 
sodium fluorescein for control rats (solid black symbols) or rats 30 minutes after intravenous injection of 15 
mg/kg TLC (solid red symbols).  B – Quantitative analysis of mean cytosolic fluorescence (± SEM) as a 
function of time after intravenous injection of sodium fluorescein for control rats (solid black symbols) or rats 30 
minutes after intravenous injection of 15 mg/kg TLC (solid red symbols). 
 
Video captions 
 
Video 1 -  Fluorescein transport in the liver of a living rat - Sequence of multiphoton excitation 
fluorescence images collected from the liver of a living rat after intravenous injection of sodium fluorescein.  
Each image is a maximum projection of 6 images collected through a 6 micron volume for each time point.  
Video represents a 10 minute interval of time. 
 
Video 2 - The effects of vertical motion can be mitigated by maximum projection of image volumes – 
Left -   Series of images collected from a single focal plane of the liver of a living rat following IV injection of 2 
mg/kg sodium fluorescein.  Right -   Series of corresponding maximum projection images of the 6 plane, 6 
micron thick volume collected over time from the same field. 
 
Video 3 – Effect of endotoxin on hepatic transport of fluorescein - Series of images collected over time 
from the liver of a living rat after intravenous injection of sodium fluorescein.  Left – Vehicle treated rat, Right – 
Rat imaged two hours after intraperitoneal injection of 4 mg/kg endotoxin.  Each image in these series is a 
maximum projection of 6 images collected through a 6 micron volume for each time point.  Video represents a 
10 minute interval of time. 
 
Video 4 – Automatically generated canalicular regions of interest for quantitative analyses of hepatic 
transport - Left – Time series of images of the liver of a living rat following intravenous injection of CGamF.  
Right – Time series of the corresponding automatically-generated regions-of-interest for measurements of 
field-wise canalicular fluorescence. 
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
  
  
 
 
  
Highlights 
 Hepatic transport can be characterized using microscopy of fluorescent transporter substrates. 
 Multiphoton microscopy can resolve hepatic transport at subcellular resolution in vivo. 
 Quantitative intravital microscopy can quantify disruptions in hepatic transport in vivo. 
 
 
